Cover Image

Evaluation of Delayed Initiation of Lenalidomide Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Koji Kawamura, Nobuhiro Tsukada, Shun‐ichi Kimura, Shinichi Kako, Daisuke Minakata, Terukazu Enami, Yasuharu Hamano, Go Yamamoto, Shuichi Ota, Naoshi Obara, Kiyoshi Ando, Kenshi Suzuki, Yoshinobu Kanda
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Hematological Oncology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adverse Impact of Pre‐Transplant Liver Dysfunction in Allogeneic Hematopoietic Cell Transplantation
by: Yukiko Misaki, et al.
Published: (2025)

Prognostic Value of C‐Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma
by: Akihiko Izumi, et al.
Published: (2025)

The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation
by: Yutaka Shimazu, et al.
Published: (2024)

Platelet Recovery and Its Impact on Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation: A Japanese Nationwide Retrospective Study
by: Naoki Kurita, et al.
Published: (2025)

Allogeneic Hematopoietic Stem Cell Transplantation in Refractory Multiple Myeloma—A Retrospective Multicenter Analysis
by: T. Richardson, et al.
Published: (2024)

Impact of Conditioning Intensity on Clinical Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Relapse After First Transplantation
by: Kazuki Yoshimura, et al.
Published: (2025)

Daratumumab, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide, and Dexamethasone in Transplant‐Ineligible Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Meta‐Analysis
by: Lucio N. Gordan, et al.
Published: (2025)

Effect of Early Administration of Anti‐MRSA Drugs for Febrile Neutropenia in Allogeneic Hematopoietic Cell Transplantation
by: Anna Akaogi, et al.
Published: (2026)

Cytomegalovirus Retinitis During Idecabtagene Vicleucel Therapy in Patients With Relapsed/Refractory Multiple Myeloma
by: Taku Kikuchi, et al.
Published: (2025)

Balancing the Risk of Cardiotoxicity Outcomes in Treatment Selection for Multiple Myeloma: A Retrospective Multicenter Evaluation of Ixazomib, Lenalidomide, and Dexamethasone (IRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (KRd)
by: Benjamin J. Lee, et al.
Published: (2025)

The Role of the Gut Microbiota in Allogeneic Hematopoietic Cell Transplantation
by: Wenjing Hao, et al.
Published: (2026)

Comparison of Time to Next Treatment or Death Between Front‐Line Daratumumab, Lenalidomide, and Dexamethasone ( DRd ) Versus Bortezomib, Lenalidomide, and Dexamethasone ( VRd ) Among Transplant‐Ineligible Patients With Multiple Myeloma
by: Doris K. Hansen, et al.
Published: (2024)

Real‐World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated With Front‐Line Daratumumab Lenalidomide and Dexamethasone
by: Ricardo D. Parrondo, et al.
Published: (2026)

Real‐world effectiveness and safety of tirzepatide in Japanese patients with type 2 diabetes: A multi‐site retrospective study
by: Yusuke Minakata, et al.
Published: (2026)

Late Cytomegalovirus Infections After Allogeneic Hematopoietic Cell Transplant
by: George L. Chen, et al.
Published: (2026)

Increased Non‐Relapse Mortality in Older People With Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine and Myeloablative Dose of Busulfan‐Based Regimen
by: Akihito Shinohara, et al.
Published: (2025)

Adenovirus‐Associated Opsoclonus After Allogeneic Hematopoietic Stem Cell Transplantation
by: Toru Miyajima, et al.
Published: (2026)

Classical and Late‐Onset SOS/VOD After Allogeneic HSCT: A Japanese Transplant Registry Analysis
by: Kyoko Masuda, et al.
Published: (2025)

Isatuximab for Delayed Red Cell Engraftment after Allogeneic Hematopoietic Cell Transplantation
by: Mary Nauffal, et al.
Published: (2024)

Increasing Access to Pediatric Allogeneic Hematopoietic Stem Cell Transplantation in South Africa
by: Candice Laverne Hendricks, et al.
Published: (2026)

Natural Gradient Interpretation of Rank-One Update in CMA-ES
by: Hamano, Ryoki, et al.
Published: (2024)

Clinical and Microbiological Insights Into Invasive Fusariosis Following Allogeneic Hematopoietic Stem Cell Transplantation: A 15‐Year Single‐Center Analysis
by: Jotaro Yamamoto, et al.
Published: (2026)

Risk Analysis of Socio‐Technical Systems With Safety Functions Using CS and CFE Methods
by: Shinichi Yamaguchi, et al.
Published: (2026)

Impact of Preanalytical Sample Preparation on the Recovery Rate of Cryopreserved Allogeneic Hematopoietic Stem Cells
by: Philipp Blüm, et al.
Published: (2026)

Daratumumab in the Management of Red Cell Aplasia Following Allogeneic Hematopoietic Stem Cell Transplantation
by: Nihar Desai, et al.
Published: (2024)

VZV Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation in Children: When to Stop?
by: Eva de Berranger, et al.
Published: (2024)

Reduction in Length of Hospital Stays for Allogeneic Hematopoietic Stem‐Cell Transplantation in the Letermovir Era
by: Hiroki Hosoi, et al.
Published: (2025)

Longitudinal logbook survey designs for estimating recreational fishery catch, with application to ayu (Plecoglossus altivelis)
by: Kitada, Shuichi, et al.
Published: (2002)

Policy Gradient Algorithms with Monte Carlo Tree Learning for Non-Markov Decision Processes
by: Morimura, Tetsuro, et al.
Published: (2022)

eV-scale sterile neutrino: A window open to non-unitarity?
by: Minakata, Hisakazu
Published: (2025)

Neutrino amplitude decomposition, $S$ matrix rephasing invariance, and reparametrization symmetry
by: Minakata, Hisakazu
Published: (2023)

EL MAESTRO QUE APRENDE: EDUCACIÓN PARA UNA NUEVA ÉPOCA
by: Alberto Minakata
Published: (2000)

Post‐Transplant Bendamustine as a Platform for Immune Modulation After Allogeneic Hematopoietic Cell Transplantation
by: Megan J. Cracchiolo, et al.
Published: (2026)

Model‐Based Prediction of Clinically Relevant Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation
by: Katharina M. Götz, et al.
Published: (2025)

CSF3R Mutations in Hematological Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
by: Jiaxin Cao, et al.
Published: (2025)

Long‐Term Survival After Allogeneic Hematopoietic Stem Cell Transplantation for BCR::ABL1‐Negative Atypical Chronic Myeloid Leukemia: A Nationwide Retrospective Study by Adult CML/MPN and MDS Working Groups of the Japanese Society for Transplantation and Cellular Therapy
by: Hidehiro Itonaga, et al.
Published: (2025)

Tacit Knowledge Management with Generative AI: Proposal of the GenAI SECI Model
by: Uchihira, Naoshi
Published: (2026)

Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children and Young Adults with Ewing Sarcoma
by: Leardini, Davide
Published: (2026)

Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With a Germline DDX41 Mutation
by: Shuro Yoshida, et al.
Published: (2024)

Myeloablative Busulfan, Fludarabine and Melphalan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Childhood Myeloid Malignancy
by: Mayank Dhamija, et al.
Published: (2026)